...
首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Intralesional vitamin D3 versus new topical photodynamic therapy in recalcitrant palmoplanter warts Randomized comparative controlled study
【24h】

Intralesional vitamin D3 versus new topical photodynamic therapy in recalcitrant palmoplanter warts Randomized comparative controlled study

机译:顽固的维生素D3与新的局部光动力学治疗在顽抗棕榈羊毛疣中随机化比较控制研究

获取原文
获取原文并翻译 | 示例

摘要

Background: Recalcitrant palmoplanter warts represent a therapeutic challenge. Side effects of local destructive methods necessitates the need for other less morbid modalities. Recently immunotherapy as well as light based devices and lasers have emerged as therapeutic approaches.Aim of the study: To compare between the safety and efficacy of intralesional vitamin D3 injection and photo dynamic therapy (PDT) using eosin in treatment of recalcitrant palmoplanter warts.Patients and Methods: Prospective, randomized, controlled comparative study. Fifty -six patients with recalcitrant palmoplanter warts were randomly divided into 3 groups. Group A was injected with intralesional vitamin D3. Group B was subjected to PDT using eosin loaded in trasferosomes as a photosensitizer. Group C is the control group. Clinical improvement was assessed by photographic records and dermoscopic assessment, at baseline, before each session and after completion of treatment. Patients were followed up for 6 months after cure to detect recurrence.Results: Group A and B showed complete clearance in 88.89 % and 86.36 % respectively compared to 18.75 % in the control group. These results were statistically significant (P value0.001). No side effects were reported except for pain during injection in group A.Conclusion: In the current study, both vitamin D3 and PDT using Eosin are safe, highly effective and well tolerated modalities in treatment of viral warts.
机译:背景:顽抗棕榈羊毛疣代表治疗挑战。局部破坏性方法的副作用需要其他较少的病态模态。最近的免疫疗法以及光线的设备和激光器已成为治疗方法。研究中的研究:在治疗RocalciTrant Palmoplanter疣中使用eosin的血吸虫治疗(PDT)的安全性和疗效进行比较和方法:前瞻性,随机,受控比较研究。顽固棕榈植物疣的五十次患者随机分为3组。 A组A注入腔内维生素D3。将B组使用蒸发素瘤作为光敏剂的曙红进行PDT。 C组是对照组。通过摄影记录和Demoscopic评估,在每次会议之前和完成治疗后,评估临床改善。治愈后的患者进行了6个月以检测复发。结果:A组和B分别显示出在对照组中分别为88.89%和86.36%的完全清除。这些结果具有统计学意义(P值<0.001)。除了在A组注射期间疼痛的疼痛没有报告副作用。结论:在目前的研究中,使用曙红的维生素D3和PDT都是安全,高效且耐受良好的病毒疣的形式。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号